All Stories

  1. Natural Products Targeting Notch Signaling in Cancer
  2. Antimicrobial self-healing injectable hydrogels based on chitosan, collagen, and polyvinyl alcohol for chronic wound treatment
  3. Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and Beyond
  4. Repurposing Poloxamers as Antimicrobial Agents: A Comprehensive Review of Mechanisms and Applications
  5. Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies
  6. Influencia del grado de desacetilación del quitosano en la síntesis de nanopartículas para aplicaciones farmacéuticas
  7. Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
  8. Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
  9. Skin Disorders and Quality of Life: An Overview
  10. D1 Receptor Functional Asymmetry at Striatonigral Neurons: A Neurochemical and Behavioral Study in Male Wistar Rats
  11. Nanoparticle and microparticle-based systems for enhanced oral insulin delivery: A systematic review and meta-analysis
  12. Unlocking the biological potential of methyl antcinate A: a new frontier in cancer and inflammation application
  13. Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease
  14. Unrevealing Lithium Repositioning in the Hallmarks of Cancer: Effects of Lithium Salts (LiCl and Li2CO3) in an In Vitro Cervical Cancer Model
  15. Natural products‐based antiangiogenic agents: New frontiers in cancer therapy
  16. Cacalol Acetate as Anticancer Agent: Antiproliferative, Pro-Apoptotic, Cytostatic, and Anti-Migratory Effects
  17. Cacalol Acetate as Anticancer Agent: Anti-proliferative, Pro-apoptotic, Cytostatic and Anti-migratory Effects
  18. Biopolymeric Insulin Membranes for Antimicrobial, Antioxidant, and Wound Healing Applications
  19. Polymeric nanoparticles decorated with fragmented chitosan as modulation systems for neuronal drug uptake
  20. Genipin’s potential as an anti-cancer agent: from phytochemical origins to clinical prospects
  21. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives
  22. Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights
  23. Review of the anticancer properties of 6‐shogaol: Mechanisms of action in cancer cells and future research opportunities
  24. Optimize the parameters for the synthesis by the ionic gelation technique, purification, and freeze-drying of chitosan-sodium tripolyphosphate nanoparticles for biomedical purposes
  25. Modulation of D3R Splicing, Signaling, and Expression by D1R through PKA→PTB Phosphorylation
  26. Skin Disorders and Quality of Life: An Overview
  27. Dopamine D3 receptor modulates D2 receptor effects on cAMP and GABA release at striatopallidal terminals—Modulation by the Ca2+–Calmodulin–CaMKII system
  28. Essential-Oils-Loaded Biopolymeric Nanoparticles as Strategies for Microbial and Biofilm Control: A Current Status
  29. Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
  30. Novel ultra-stretchable and self-healing crosslinked poly (ethylene oxide)-cationic guar gum hydrogel
  31. 3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways
  32. Recombinant Antibodies to Face SARS-CoV-2 Syndemic
  33. High Levels of Anxiety, Depression, Risk of Suicide, and Implications for Treatment in Patients with Lamellar Ichthyosis
  34. Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents
  35. PEG 400:Trehalose Coating Enhances Curcumin-Loaded PLGA Nanoparticle Internalization in Neuronal Cells
  36. Enhancing chemical and physical stability of pharmaceuticals using freeze-thaw method: challenges and opportunities for process optimization through quality by design approach
  37. Current Status of the Therapeutic Approach for Dysmenorrhea
  38. Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
  39. Lithium: A Promising Anticancer Agent
  40. Discovering the effect of solvents on poly(2-aminoethyl methacrylate) grafting onto chitosan for an in vitro skin model
  41. Study of Traditional Uses, Extraction Procedures, Phytochemical Constituents, and Pharmacological Properties of Tiliacora triandra
  42. Preparation of chitosan-graft N-hydroxyethyl acrylamide copolymers as an in vitro-engineered skin
  43. Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization
  44. Presynaptic nigral GPR55 receptors stimulate [ 3 H]‐GABA release through [ 3 H]‐cAMP production and PKA activation and promote motor behavior
  45. Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest
  46. The high methylation level of a novel 151-bp CpG island in the ESR1 gene promoter is associated with a poor breast cancer prognosis
  47. A poly (saccharide-ester-urethane) scaffold for mammalian cell growth
  48. Gamma radiation-induced grafting of poly(2-aminoethyl methacrylate) onto chitosan: A comprehensive study of a polyurethane scaffold intended for skin tissue engineering
  49. Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer
  50. Alterations in mental health and quality of life in patients with skin disorders: a narrative review
  51. Therapeutic Applications of Terpenes on Inflammatory Diseases
  52. A NEW FORMULATION OF CINNAMON OIL AND CHITOSAN DEPOLYMERIZED AGAINST OPPORTUNISTIC MICROORGANISMS DURING WOUND HEALING
  53. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses
  54. Current progress of self-healing polymers for medical applications in tissue engineering
  55. Insights into Terminal Sterilization Processes of Nanoparticles for Biomedical Applications
  56. Antioxidant potential of family Cucurbitaceae with special emphasis on Cucurbita genus: A key to alleviate oxidative stress‐mediated disorders
  57. Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials
  58. Association of TLR4 gene polymorphisms with sepsis after a burn injury: findings of the functional role of rs2737190 SNP
  59. Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy
  60. Development of a guar gum film with lysine clonixinate for periodontal treatments
  61. Development of a xanthan gum film for the possible treatment of vaginal infections
  62. Development of films from natural sources for infections during wound healing
  63. Physicochemical and biological characterization of a xanthan gum-polyvinylpyrrolidone hydrogel obtained by gamma irradiation
  64. Radiation-induced graft polymerization of elastin onto polyvinylpyrrolidone as a possible wound dressing
  65. Synthesis by gamma irradiation of hyaluronic acid-polyvinyl alcohol hydrogel for biomedical applications
  66. Repurposing of Drug Candidates for Treatment of Skin Cancer
  67. Increased risk of depression and impairment in quality of life in patients with lamellar ichthyosis
  68. Dopamine D4 receptor modulates inhibitory transmission in pallido‐pallidal terminals and regulates motor behavior
  69. Gamma radiation-induced grafting of n-hydroxyethyl acrylamide onto poly(3-hydroxybutyrate): A companion study on its polyurethane scaffolds meant for potential skin tissue engineering applications
  70. Chitosan-decorated nanoparticles for drug delivery
  71. A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
  72. Radiation-induced PEGylated Ethambutol Has Low Antimycobacterial Activity in Vitro
  73. RECENT ADVANCES IN ELASTIN-BASED BIOMATERIALS
  74. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family
  75. Xanthan gum in drug release
  76. Hyaluronic acid in wound dressings
  77. High prevalence of autosomal recessive congenital ichthyosis in a Mexican population caused by a new mutation in the TGM1 gene: epidemiological evidence of a founder effect
  78. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
  79. Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7
  80. Coexistence of D 3 R typical and atypical signaling in striatonigral neurons during dopaminergic denervation. Correlation with D 3 nf expression changes
  81. Breast cancer-related single-nucleotide polymorphism and their risk contribution in Mexican women
  82. D 2 autoreceptor switches CB 2 receptor effects on [ 3 H]‐dopamine release in the striatum
  83. Non-invasive methods for evaluation of skin manifestations in patients with ichthyosis
  84. Pharmacological treatments for cutaneous manifestations of inherited ichthyoses
  85. Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction Among Glutamate, Dopamine, and GABA
  86. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
  87. Development and Evaluation of Alginate Membranes with Curcumin-Loaded Nanoparticles for Potential Wound-Healing Applications
  88. Modifications in Vaginal Microbiota and Their Influence on Drug Release: Challenges and Opportunities
  89. Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1
  90. Presynaptic Control of [3H]-Glutamate Release by Dopamine Receptor Subtypes in the Rat Substantia Nigra. Central Role of D1 and D3 Receptors
  91. Formulations of Curcumin Nanoparticles for Brain Diseases
  92. Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7
  93. Non-invasive analysis of skin mechanical properties in patients with lamellar ichthyosis
  94. Comprehensive mapping of human body skin hydration: A pilot study
  95. Presynaptic cannabinoid CB2 receptors modulate [3 H]-Glutamate release at subthalamo-nigral terminals of the rat
  96. From traditional biochemical signals to molecular markers for detection of sepsis after burn injuries
  97. Origin of the myotonic dystrophy type 1 mutation in Mexican population and influence of Amerindian ancestry on CTG repeat allelic distribution
  98. Presynaptic Dopamine D2 Receptors Modulate [ 3 H]GABA Release at StriatoPallidal Terminals via Activation of PLC → IP3 → Calcineurin and Inhibition of AC → cAMP → PKA Signaling Cascades
  99. Nanotechnology As Potential Tool for siRNA Delivery in Parkinson's Disease
  100. Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent
  101. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain
  102. Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2+ dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat
  103. Detección de la duplicación del gen PMP22 en pacientes con neuropatía periférica: estudio en la población mexicana
  104. Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca2+ dependent manner
  105. Origin of the Spinocerebellar Ataxia Type 7 Gene Mutation in Mexican Population
  106. GABAB receptors modulate depolarization-stimulated [3H]glutamate release in slices of the pars reticulata of the rat substantia nigra
  107. L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors